India Drug Delivery Devices Market to Grow with a CAGR of 6.11% through 2030

Increasing Adoption of Biologics and Targeted Therapies is expected to drive the India Drug Delivery Devices Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “India Drug Delivery Devices Market -By Region, Competition, Forecast and Opportunities, 2020-2030”, the India Drug Delivery Devices Market stood at USD 12.70 Billion in 2024 and is anticipated to grow with a CAGR of 6.11% through 2030. Biologic therapies, including monoclonal antibodies, gene therapies, and other complex biologics, are becoming increasingly crucial in the treatment of chronic diseases such as cancer, autoimmune disorders, and diabetes. These therapies often necessitate specialized drug delivery systems, such as injectables or infusion devices, to ensure their efficacy and proper administration. Due to their large, complex molecular structure, biologics and targeted therapies cannot be taken orally as they are unstable in the digestive system. Consequently, they require advanced drug delivery devices, such as injectors, auto-injectors, pens, and infusion pumps, to facilitate accurate and controlled delivery into the bloodstream.

Targeted therapies, designed to address specific disease mechanisms, offer more precise treatment with fewer side effects compared to traditional therapies. These therapies typically require controlled-release formulations and precision delivery systems that ensure the drug reaches the target site in the correct dosage at the optimal time, further driving the demand for advanced drug delivery technologies.

The adoption of biologics, particularly in oncology and immunotherapy, is rapidly growing in India. Treatments like monoclonal antibodies for cancer and biologic drugs for autoimmune diseases require specialized devices for effective and accurate administration, thereby boosting demand for injectable drug delivery systems. Biologic treatments often involve long-term use, which can be burdensome for patients if the delivery process is complex. The development of user-friendly drug delivery devices, such as self-administration pens and auto-injectors, enhances patient compliance by making it easier for patients to administer biologics at home.

The increasing focus on biologics and targeted therapies has spurred significant investment in the development of innovative drug delivery systems, leading to more efficient, cost-effective, and patient-friendly solutions. This, in turn, accelerates the adoption of biologics and targeted treatments. As a result, the rising use of biologics and targeted therapies is driving the demand for specialized drug delivery devices in India, as these treatments require advanced systems to optimize efficacy, improve patient outcomes, and ensure proper administration. 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India Drug Delivery Devices Market”

The India Drug Delivery Devices Market is segmented into devices, route of administration, application, end user, regional distribution, and company.

Based on end user, hospitals emerged as the dominating segment in the Indian Drug Delivery Devices Market in 2024. Hospitals serve as primary points of healthcare delivery, catering to a wide range of medical needs, from routine check-ups to complex surgical procedures. Due to their extensive patient base and comprehensive healthcare services, hospitals drive substantial demand for various drug delivery devices. Within hospitals, drug delivery devices find diverse applications across departments such as surgery, critical care, oncology, and chronic disease management. For instance, infusion pumps are widely utilized in hospital settings for precise administration of medications and fluids during surgeries, intensive care, and chemotherapy sessions. Similarly, inhalers and nebulizers are essential for respiratory therapy in hospital wards treating patients with asthma, COPD, or other respiratory conditions. Hospitals often have dedicated pharmacies or drug dispensing units where patients can access medications and drug delivery devices prescribed by healthcare professionals. This integrated approach facilitates seamless procurement and utilization of drug delivery devices within the hospital ecosystem. While diagnostic centres and ambulatory surgery centres also contribute to the demand for drug delivery devices, their scope of usage is comparatively narrower, primarily focusing on specific diagnostic procedures or outpatient surgeries. Thus, hospitals remain the dominant force shaping the Indian Drug Delivery Devices Market, driven by their extensive healthcare infrastructure and diverse patient care requirements.

Based on the region, the South India emerged as the fastest growing region in the Indian Drug Delivery Devices market during the forecast period. South India is a key hub for the pharmaceutical and biotech industries, particularly in cities like Hyderabad, Bengaluru, Chennai, and Kochi. These cities are renowned for their strong pharmaceutical manufacturing base and advanced research and development (R&D) infrastructure. This concentration of pharmaceutical companies has driven the demand for advanced drug delivery devices, as local manufacturers introduce innovative products to meet both domestic and international market needs. The region is also home to a well-established healthcare infrastructure, with numerous top-tier hospitals, diagnostic centers, and medical institutions, especially in Bengaluru, Chennai, and Hyderabad. This robust healthcare ecosystem supports the growing adoption of advanced drug delivery systems, including insulin pens, auto-injectors, and biologic delivery devices, essential for managing chronic conditions. South India has experienced a significant rise in chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders. Particularly, the high prevalence of diabetes has spurred demand for drug delivery devices like insulin pens and auto-injectors.  The state governments in South India have actively supported the pharmaceutical and healthcare sectors through various initiatives, fostering an environment conducive to the growth of drug delivery devices. For example, Karnataka, a major player in India's pharmaceutical sector, has policies aimed at boosting biotechnology and healthcare innovation. Furthermore, the government's investment in healthcare infrastructure and initiatives like the Pharmaceuticals and Biotechnology Development Policy have contributed to the region’s growth in drug delivery. South India also hosts a strong presence of both global and domestic medical device companies. The region boasts numerous manufacturing units, R&D centers, and distribution networks for drug delivery devices, increasing local production and availability of advanced devices such as needle-free injectors, insulin pens, and controlled-release systems, further driving market growth. The region benefits from a highly skilled workforce, especially in biotechnology, pharmaceuticals, and healthcare technology. Prestigious institutions like IIT Madras, IISc Bengaluru, and NIPER foster innovation in drug delivery technologies, accelerating the development and adoption of new devices. With its combination of strong industrial capacity, skilled workforce, high healthcare awareness, and government support, South India stands as a key driver of innovation and growth in the drug delivery devices market.

Major companies operating in India Drug Delivery Devices Market are:

• Pfizer Ltd.
• Novartis India Ltd.
• GlaxoSmithKline Pharmaceuticals Ltd.
• India Medtronic Private Ltd.
• Cardinal Health International India Pvt Ltd.
• B. Braun Medical (India) Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd.
• 3M India Ltd.
• Cipla Ltd.
• Bayer Zydus Pharma

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The Indian drug delivery devices market is projected to experience substantial growth over the forecast period. This growth is primarily driven by the increasing demand for drug delivery systems and a rising awareness of health issues among the population. The market is further fueled by technological advancements and the introduction of innovative products designed to effectively manage a range of diseases. Rapid developments in the healthcare sector have heightened the demand for drug delivery devices in India. As lifestyle changes and the prevalence of chronic and fatal diseases rise, the need for efficient drug delivery systems becomes more critical. These devices are essential for ensuring the accurate and timely administration of medications, ultimately improving patient outcomes. With continued advancements in technology and a growing emphasis on enhancing healthcare outcomes, the Indian drug delivery devices market is set for significant growth in the years ahead,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“India Drug Delivery Devices Market By Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch), By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Others), By Application (Cancer, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Others), By End User (Hospitals, Diagnostic Centres, Ambulatory Surgery Centres, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of India Drug Delivery Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Drug Delivery Devices Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com